BASTIDE: Description of the share buyback program voted by the AGM of December 13, 2023 – 12/21/2023 at 6:00 p.m.

BASTIDE

Limited company with capital of 3,355,874.55 euros

The head office :

12, avenue de la Dame, Eurozone 2000

30132 Caissargues

305 635 039 RCS NIMES

Description of the share buyback program voted by the shareholders

during the Combined General Meeting of December 13, 2023

In accordance with the provisions of Article 5 of Regulation 596/2014, Article 2 of Delegated Regulation 2016/1052 and Article 241-2 of the AMF General Regulation, the purpose of this description is to describe the purposes and terms of the company’s share buyback program.

1) Date of the General Meeting authorizing the share buyback program

December 13, 2023

2) Number of securities and share of capital that the issuer holds directly or indirectly:

As of December 13, 2023, the company holds 52,802 treasury shares, or 0.708% of the capital.

3) Distribution by objectives of equity securities held by the Company

• 2,619 shares under the AMAFI liquidity contract

• 21,849 shares under the repurchase contract,

• 28,334 own shares.

4) Objectives of the buyback program

Acquisitions may be made with a view to:

– to ensure the animation of the secondary market or the liquidity of the Bastide le confort medical share through an investment service provider through a liquidity contract in accordance with the charter of ethics of the AMAFI admitted by the AMF;

– to retain the purchased shares and subsequently return them for exchange or payment as part of possible external growth operations, it being specified that the shares acquired for this purpose cannot exceed 5% of the company’s capital;

– to ensure coverage of stock option plans and other forms of share allocation to employees and/or corporate officers of the group under the conditions and according to the terms provided for by law, in particular for participation in the company’s results, under a company savings plan or by free allocation of shares within the framework of the provisions of article L.225-197-1 et seq. Trade code ;

– to ensure coverage of transferable securities giving right to the allocation of shares in the company within the framework of the regulations in force;

– to proceed with the possible cancellation of the acquired shares

5) Maximum share of capital, maximum number and characteristics of securities that the company intends to acquire and maximum purchase price

The general meeting of December 13, 2023 authorized the Bastide company to purchase shares of the company within the limit of 10% of the number of shares making up the share capital, i.e. on the basis of the current capital, 754,750 actions. Also, the amount of the program cannot be greater than the amount of free reserves established in the annual corporate accounts for the current financial year.

Taking into account the number of shares held as of December 13, 2023, i.e. 52,802 shares representing 0.708% of the capital, the maximum number of shares that can be purchased under this authorization amounts to 701,948, i.e. a theoretical investment of 49,136 .360 euros based on the maximum purchase price of 70 euros appearing in the eighteenth resolution of the general meeting of shareholders.

6) Duration of the buyback program

The authorization will expire at the end of the general meeting called to approve the accounts for the financial year ending June 30, 2024.

© Copyright Actusnews Wire

Receive future company press releases free of charge by email by subscribing to www.actusnews.com